KBI Biopharma, Inc., a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), has entered into a manufacturing agreement with Alanis Therapeutics, Inc. to develop a pre-clinical therapeutic antibody aimed at treating myelodysplastic syndromes (MDS) and
KBI Biopharma Inc., a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), has extended and expanded its manufacturing contract with a leading global pharmaceutical company. The renewed contract, originally initiated in 2020, now extends through
KBI Biopharma is a Manufacturer/Innovator, CMO/CDMO, Biopharmaceutical company, Generics/Biosimilars Manufacturer company operating in the pharmaceutical industry. KBI Biopharma, Inc., a JSR Life Sciences company, together with its affiliates, is a global contract development and manufacturing organization (CDMO) providing fully integrated,
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
